Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Soybean Oil For Injection BP EP USP Pharma Grade is a purified, refined oil sourced directly from the seeds of the Glycine max plant, better known as the soybean. Strict manufacturing protocols eliminate impurities, proteins, and free fatty acids to render it suitable for pharmaceutical use and sensitive medical applications. Transparent and pale yellow, this liquid stands apart from technical or industrial versions because pharmacopoeia standards—British (BP), European (EP), and United States (USP)—set specific benchmarks for safety, purity, and consistency. No additives disrupt its molecular structure, so the product remains a clean triglyceride blend. Clinical formulations trust this oil, whether carrying fat-soluble vitamins, dissolving drug actives, or serving as a lipid vehicle in parenteral nutrition. Pharmacies, compounding labs, and hospitals depend on its unbroken supply because patient safety hinges on proven, incremental production measures.
The molecular formula for standard pharmaceutical soybean oil reads as C57H104O6, with a molecular weight of about 885 g/mol. Unchanged by crystallization or flaking, it pours freely at room temperature, presenting as a clear, light-yellow fluid with a faint odor. Inspecting its internal arrangement, it largely contains triglycerides, including linoleic acid (40-60%), oleic acid (19-30%), and smaller amounts of palmitic and stearic acids. Specific density sits around 0.917–0.925 g/cm3 at 25°C—higher than many mineral oils but lighter than castor oil, reducing load on sensitive equipment and infusion lines. No solid, crystalline, flake, pearl, or powdered forms exist for this grade; it remains fluid in all storage and dosing conditions within the clinical range. Refractive index usually ranges between 1.466 and 1.474 at 25°C, signaling genuine clarity and absence of emulsifiers or unwanted residues.
Close molecular inspection shows a triglyceride backbone—glycerol joined with fatty acid chains. No phosphate groups, proteins, sterols, or trace allergens persist in the material, because manufacturers filter, deodorize, and carefully refine each batch. As a consequence, no harmful peroxides or oxidized byproducts remain within pharma grade boundaries. Chemical inertia keeps the oil from reacting with most injectable drugs; the hydrolytic stability means degradation rarely arises under recommended storage. Absence of colorants or stabilizers ensures the material maintains simplicity, so patients with hypersensitivity rarely encounter issues.
Hospitals and pharmaceutical labs hold this oil in high regard. Injectable emulsions—think fat-milks for intravenous feeding—use it as a cornerstone ingredient. No mixing with water, alcohol, or powders occurs at the point of care; the product flows straight from a sterile vial, processed under current Good Manufacturing Practices (cGMP). Sensitive lighting and low-oxygen environments protect the oil from atmospheric breakdown during shipment and storage. Volatility remains low, so spills rarely evaporate, and density consistency helps dosing technicians draw exact volumes with calibrated instruments.
Producers source soybeans from non-GMO or identity-preserved agriculture to meet regulatory demand for purity and traceability, especially in regions with strict supply chain controls. Extraction skips harsh chemical solvents, favoring mechanical press methods followed by several rounds of purification. Farmers and upstream processors coordinate closely with labs to keep pesticide residues, heavy metals, and microbiological contaminants below detection limits. Each batch yields a full testing certificate, confirming fatty acid composition, absence of protein, and exceptional clarity, so clinicians always know what’s going into the patient.
International trade identifies Soybean Oil For Injection Pharma Grade under HS Code 1507 (soya-bean oil and its fractions, whether or not refined, not chemically modified). Yet products qualified as medical or pharmaceutical raw materials often fall under narrower customs entries, depending on the destination region’s regulatory framework. Documentation accompanies every shipment to ensure uninterrupted transparency and compliance with both pharmacopoeia and customs authorities—no ambiguity, only straight facts and traceable paperwork.
On the safety front, pharmaceutical soybean oil carries no known hazard when prepared to BP EP USP parameters. No volatile organic compounds threaten warehouse workers, and accidental skin contact rarely causes irritation. Injections occur only under medical supervision, to eliminate the risk of embolism or allergic reaction. Material safety data sheets spell out emergency measures for spillage—soap and water for cleanup, with focus kept on sterility rather than toxicity. Unlike technical-grade soy oil, pharma grade contains no chemical residues, no Polychlorinated Biphenyls (PCBs), and no new allergenic proteins, so end users rely on its record of protection.
Demand for injectable soybean oil shows no sign of fading, with the share in parenteral nutrition and drug delivery holding steady across continents. The oil’s physical properties—low density, high purity, fluidity under standard hospital conditions—beat synthetic or animal-derived alternatives on both safety and patient tolerance. Molecular reliability forms the backbone of successful clinical interventions, reducing post-market complaints and regulatory recalls. When patients’ lives depend on total composition transparency, suppliers and pharmacists come to value every lab test, every origin certificate, every milliliter filled. Supply chains rebuild trust batch by batch, bottle by bottle, as healthcare turns on details and proven science, not shortcuts.
Chengguan District, Lanzhou, Gansu, China
